Jaime Rubio-Perez

7PUBLICATIONS
19CO-AUTHORS
Molecular targetsPublic health nutritionCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 05, 2026
Type II ROS1 Inhibition Overcomes Type I Inhibitor Resistance in ROS1 Fusion-Positive Lung Cancers: A Phase II Trial of Cabozantinib.

|Nov 27, 2025
Feasibility and Acceptability of the Cancer-Specific PRONTO Protocol for Nutritional Risk Screening in Outpatient Oncology Cancer Care: A Pilot Study.

Darío Sánchez-Cabrero, Jaime Rubio, Jorge Durá Esteve

|Oct 27, 2022
MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients.

Andrea Santos, Ion Cristóbal, Jaime Rubio

|Feb 26, 2022
MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients.

Andrea Santos, Ion Cristóbal, Jaime Rubio

|Oct 13, 2021
Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients.

Ion Cristóbal, Andrea Santos, Jaime Rubio

|Apr 03, 2021
Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer.

Jaime Rubio, Ion Cristóbal, Andrea Santos

Pageof 2

Frequent Collaborators

5 joint publications

Cristina Caramés

3 joint publications

Juan Madoz-Gúrpide

2 joint publications

Ion Cristóbal

1 joint publications

Laura Guzmán-Gómez